2021 was the first year in which US multinationals abroad spent more on R&D in services than in manufacturing. This reflects a fundamental shift in the R&D activities of US MNEs, and in our perceptions of R&D internationalization. Information, software, business, and scientific services have displaced automotive or pharmaceuticals as the main R&D investing industries. This shift also changes the relative importance of host countries; the European Union, with its specialization on manufacturing, is losing ground against Asian economies, but also other OECD countries.
No takes yet. Share an insight, caveat, or question.
Bernhard Dachs (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: